Osteochondrosis is a dubious disease in the field of genetic metabolism, clinical performance is complex and often involves multi-systematic stress. Early identification and standardized clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
Platforms can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of osteochondrosis treatment programs need to be individualized, typically including drug therapy, rehabilitation interventions, and regular follow-up dimension management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic diseases have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule of changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of osteochondrosis. The platform serves China International Medical Service System, a team of domestic and foreign experts in the field of genetic metabolism, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.